Prize Recipients

2025 Prize

CAR T-cell Therapy

Prize Recipients:
Carl June, University of Pennsylvania Perelman School of Medicine • Bruce Levine, University of Pennsylvania Perelman School of Medicine • Isabelle Rivière, Takeda • Michel Sadelain, Columbia University

Citation: For developing chimeric antigen receptor (CAR) T-cell technology for personalized and scalable cancer immunotherapy. By genetically engineering a patient’s own immune cells, CAR T-cells precisely target and destroy cancer cells. CAR T-cell therapy has provided durable remission for tens of thousands of patients with otherwise incurable blood cancers.

Read more

Carl June, Bruce Levine, Isabelle Rivière, Michel Sadelain
Developers of the technology behind CAR T-cell therapies for cancer and winners of the 2025 Merkin Prize in Biomedical Technology: Carl June, Bruce Levine, Isabelle Rivière, Michel Sadelain
Credit: University of Pennsylvania Perelman School of Medicine, Columbia University Irving Medical Center

For recipent bios, click here.

Past Recipients

2024
The T7 Expression System
F. William Studier, Brookhaven National Laboratory

 

Citation: For developing technology that uses components of the T7 bacteriophage for rapid, cell-free, and bacterial expression of any gene of interest. By enabling the production of critical proteins and RNAs on a massive scale, the T7 Expression System has accelerated biomedical research and has helped to extend millions of lives worldwide through its use in therapeutics, diagnostics, and vaccines, including the mRNA vaccines that protect against COVID-19.

Read more

 

 

 

 

2023
Efficient DNA Synthesis
Marvin H. Caruthers, University of Colorado

 

Citation: For developing methods enabling efficient, accurate synthesis of specified DNA and RNA sequences, making possible the genomic revolution in biological science and medicine and improving the lives of hundreds of millions of people globally through diagnostic tests and genetic medicines.

Read more